GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
+10.84%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.02B
AUM Growth
+$161M
(+8.7%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
30.42%
Holding
198
New
9
Increased
53
Reduced
120
Closed
15
Top Buys
| 1 |
TWOU
2U, Inc.
TWOU
|
$24.1M |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
$18.3M |
| 3 |
HealthEquity
HQY
|
$12.8M |
| 4 |
Materion
MTRN
|
$11.8M |
| 5 |
RDNW
RideNow Group, Inc. Class B Common Stock
RDNW
|
$9.19M |
Top Sells
| 1 |
Kornit Digital
KRNT
|
$18.5M |
| 2 |
Knight Transportation
KNX
|
$13.6M |
| 3 |
RingCentral
RNG
|
$11.9M |
| 4 |
DMC Global
BOOM
|
$11.3M |
| 5 |
Strategic Education
STRA
|
$9.43M |
Sector Composition
| 1 | Technology | 36.51% |
| 2 | Healthcare | 18.89% |
| 3 | Industrials | 13.46% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Real Estate | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Neuronetics
STIM
$219M
| $1.67M | 0.08% |
133,649
-18,831
| -12% | -$236K |
|
152
CytomX Therapeutics
CTMX
$346M
| $1.65M | 0.08% |
147,223
-9,168
| -6% | -$103K |
|
153
Iterum Therapeutics
ITRM
$28.2M
| $1.6M | 0.08% |
15,524
+71
| +0.5% | +$7.33K |
|
154
Spero Therapeutics
SPRO
$120M
| $1.59M | 0.08% |
138,295
-2,231
| -2% | -$25.7K |
|
155
CRISPR Therapeutics
CRSP
$4.8B
| $1.5M | 0.07% |
31,927
-730
| -2% | -$34.4K |
|
|
AERI
156
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.5M | 0.07% |
50,685
+16,009
| +46% | +$473K |
|
|
MLNT
157
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $1.48M | 0.07% |
222,571
-6,459
| -3% | -$43K |
|
|
GTT
158
DELISTED
GTT Communications, Inc.
GTT
| $1.39M | 0.07% |
78,937
-10,753
| -12% | -$189K |
|
159
Trupanion
TRUP
$1.92B
| $1.37M | 0.07% |
37,946
-9,008
| -19% | -$325K |
|
|
HTGM
160
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $1.34M | 0.07% |
4,472
-90
| -2% | -$26.9K |
|
161
Editas Medicine
EDIT
$227M
| $1.26M | 0.06% |
50,796
-1,532
| -3% | -$37.9K |
|
162
Sangamo Therapeutics
SGMO
$160M
| $1.02M | 0.05% |
94,249
-2,652
| -3% | -$28.6K |
|
163
Vail Resorts
MTN
$5.9B
| $1.01M | 0.05% |
4,512
-10,894
| -71% | -$2.43M |
|
164
Xenon Pharmaceuticals
XENE
$2.98B
| $969K | 0.05% |
98,259
-10,420
| -10% | -$103K |
|
165
Intellia Therapeutics
NTLA
$1.25B
| $903K | 0.04% |
55,163
-1,597
| -3% | -$26.1K |
|
|
ETTX
166
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $894K | 0.04% |
138,541
-6,042
| -4% | -$39K |
|
|
TOWR
167
DELISTED
Tower International, Inc.
TOWR
| $774K | 0.04% |
+39,702
| New | +$774K |
|
168
Match Group
MTCH
$9B
| $745K | 0.04% |
11,074
-7,149
| -39% | -$481K |
|
169
Cidara Therapeutics
CDTX
$1.65B
| $735K | 0.04% |
21,866
-186
| -0.8% | -$6.25K |
|
|
RP
170
DELISTED
RealPage, Inc.
RP
| $669K | 0.03% |
11,360
-8,324
| -42% | -$490K |
|
|
PRTK
171
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $664K | 0.03% |
166,512
-2,263
| -1% | -$9.02K |
|
172
Hudson Technologies
HDSN
$452M
| $617K | 0.03% |
717,834
-618,224
| -46% | -$531K |
|
|
MIXT
173
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $582K | 0.03% |
38,712
-6,247
| -14% | -$93.9K |
|
|
JNCE
174
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $575K | 0.03% |
116,080
-9,453
| -8% | -$46.8K |
|
175
Angi Inc
ANGI
$794M
| $563K | 0.03% |
4,325
-116
| -3% | -$15.1K |
|